Abbott Laboratories (ABT) Raw Materials (2009 - 2026)

Abbott Laboratories' Raw Materials history runs 18 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

• In Q1 2026, Raw Materials rose 2.08% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $1.7 billion (up 2.08% YoY), while the FY2025 annual figure was $1.6 billion, down 2.78% from the prior year.
• Raw Materials came in at $1.7 billion for Q1 2026 at Abbott Laboratories, up from $1.6 billion in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $2.0 billion in Q2 2023 to a low of $1.5 billion in Q1 2022.
• A 5-year average of $1.7 billion and a median of $1.7 billion in 2022 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials rose 26.08% in 2023 and fell 10.73% in 2025, its largest moves.
• Abbott Laboratories' Raw Materials stood at $1.7 billion in 2022, then grew by 7.64% to $1.8 billion in 2023, then dropped by 8.97% to $1.7 billion in 2024, then declined by 2.78% to $1.6 billion in 2025, then rose by 7.03% to $1.7 billion in 2026.
• According to Business Quant data, Raw Materials over the past three periods registered $1.7 billion, $1.6 billion, and $1.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison